Literature DB >> 11106149

Mecamylamine increases cigarette smoking in psychiatric patients.

C E Marx, E McIntosh, W H Wilson, J P McEvoy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11106149     DOI： 10.1097/00004714-200012000-00023

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  3 in total

1.  Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.

Authors:  Xiu Liu
Journal:  Psychopharmacology (Berl)       Date:  2013-05-28       Impact factor: 4.530

2.  Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study.

Authors:  Sherry A McKee; Andrea H Weinberger; Emily L R Harrison; Sabrina Coppola; Tony P George
Journal:  Schizophr Res       Date:  2009-08-22       Impact factor: 4.939

Review 3.  Design, analysis, and presentation of crossover trials.

Authors:  Edward J Mills; An-Wen Chan; Ping Wu; Andy Vail; Gordon H Guyatt; Douglas G Altman
Journal:  Trials       Date:  2009-04-30       Impact factor: 2.279
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.